Healthinvest Partners Ab Lowered Pfizer (PFE) Position; Shorts at Invitation Homes (INVH) Raised By 1.03%

March 21, 2018 - By Ruchi Gupta

Healthinvest Partners Ab decreased Pfizer Inc (PFE) stake by 11.47% reported in 2017Q3 SEC filing. Healthinvest Partners Ab sold 23,500 shares as Pfizer Inc (PFE)’s stock declined 3.45%. The Healthinvest Partners Ab holds 181,300 shares with $6.47M value, down from 204,800 last quarter. Pfizer Inc now has $216.91 billion valuation. The stock increased 0.37% or $0.1334 during the last trading session, reaching $36.4634. About 4.41 million shares traded. Pfizer Inc. (NYSE:PFE) has declined 2.76% since March 21, 2017 and is downtrending. It has underperformed by 19.46% the S&P500.

Invitation Homes Inc (NYSE:INVH) had an increase of 1.03% in short interest. INVH’s SI was 17.70 million shares in March as released by FINRA. Its up 1.03% from 17.51 million shares previously. With 2.93M avg volume, 6 days are for Invitation Homes Inc (NYSE:INVH)’s short sellers to cover INVH’s short positions. The SI to Invitation Homes Inc’s float is 9.99%. The stock decreased 0.96% or $0.215 during the last trading session, reaching $22.105. About 605,863 shares traded. Invitation Homes Inc. (NYSE:INVH) has 0.00% since March 21, 2017 and is . It has underperformed by 16.70% the S&P500.

Investors sentiment increased to 1.06 in 2017 Q3. Its up 0.10, from 0.96 in 2017Q2. It increased, as 53 investors sold PFE shares while 700 reduced holdings. 106 funds opened positions while 620 raised stakes. 4.06 billion shares or 0.86% more from 4.02 billion shares in 2017Q2 were reported. 31.99M were accumulated by Capital Investors. Benin Management has 17,840 shares. Papp L Roy & Assocs stated it has 0.17% of its portfolio in Pfizer Inc. (NYSE:PFE). Longview Partners (Guernsey) holds 4.7% of its portfolio in Pfizer Inc. (NYSE:PFE) for 24.37 million shares. 281,667 were accumulated by Rothschild Corporation Il. Winslow Evans And Crocker Incorporated owns 44,526 shares. Troy Asset Mngmt Limited owns 33,000 shares. 555,290 were accumulated by Payden & Rygel. Dodge & Cox has invested 0.02% of its portfolio in Pfizer Inc. (NYSE:PFE). Ghp Inv Advsrs has invested 0.07% in Pfizer Inc. (NYSE:PFE). The Massachusetts-based Panagora Asset Management Inc has invested 0.47% in Pfizer Inc. (NYSE:PFE). Stadion Money Mgmt Ltd Llc owns 14,978 shares. Bluemountain Capital Mngmt Lc, a New York-based fund reported 101,617 shares. Cornerstone Investment Limited Liability Company has 3.06 million shares for 2.39% of their portfolio. Fenimore Asset Mngmt reported 11,995 shares or 0.02% of all its holdings.

Analysts await Pfizer Inc. (NYSE:PFE) to report earnings on May, 1. They expect $0.73 EPS, up 5.80% or $0.04 from last year’s $0.69 per share. PFE’s profit will be $4.34B for 12.49 P/E if the $0.73 EPS becomes a reality. After $0.62 actual EPS reported by Pfizer Inc. for the previous quarter, Wall Street now forecasts 17.74% EPS growth.

Since December 15, 2017, it had 0 buys, and 12 insider sales for $12.99 million activity. 6,750 shares valued at $249,750 were sold by MACKENZIE ALEXANDER R on Friday, December 15. Dolsten Mikael sold $2.39 million worth of stock or 64,587 shares. Another trade for 9,510 shares valued at $353,677 was sold by LUND-JURGENSEN KIRSTEN. Another trade for 33,368 shares valued at $1.24 million was made by SUSMAN SALLY on Monday, February 26. $64,679 worth of stock was sold by CORNWELL W DON on Monday, February 26. The insider LANKLER DOUGLAS M sold 50,000 shares worth $1.84 million. JOHNSON RADY A sold $296,560 worth of Pfizer Inc. (NYSE:PFE) on Friday, December 15.

Among 22 analysts covering Pfizer (NYSE:PFE), 10 have Buy rating, 1 Sell and 11 Hold. Therefore 45% are positive. Pfizer had 75 analyst reports since July 29, 2015 according to SRatingsIntel. BMO Capital Markets maintained the shares of PFE in report on Tuesday, November 21 with “Buy” rating. The firm has “Buy” rating by Argus Research given on Wednesday, July 29. Jefferies maintained the shares of PFE in report on Thursday, July 13 with “Hold” rating. Jefferies maintained Pfizer Inc. (NYSE:PFE) on Thursday, October 26 with “Hold” rating. Cowen & Co maintained Pfizer Inc. (NYSE:PFE) on Monday, July 10 with “Buy” rating. Piper Jaffray maintained Pfizer Inc. (NYSE:PFE) on Saturday, September 5 with “Overweight” rating. The stock has “Equal-Weight” rating by Barclays Capital on Tuesday, December 1. As per Wednesday, November 2, the company rating was downgraded by Argus Research. The company was maintained on Monday, October 16 by SunTrust. Jefferies maintained the stock with “Hold” rating in Monday, October 16 report.

Among 11 analysts covering Invitation Homes (NYSE:INVH), 9 have Buy rating, 0 Sell and 2 Hold. Therefore 82% are positive. Invitation Homes had 12 analyst reports since February 27, 2017 according to SRatingsIntel. The firm has “Buy” rating by Bank of America given on Monday, February 27. JMP Securities initiated the stock with “Mkt Outperform” rating in Monday, February 27 report. As per Monday, February 27, the company rating was initiated by JP Morgan. The stock of Invitation Homes Inc. (NYSE:INVH) has “Buy” rating given on Thursday, March 30 by RBC Capital Markets. FBR Capital initiated Invitation Homes Inc. (NYSE:INVH) on Monday, February 27 with “Outperform” rating. The rating was initiated by Wells Fargo with “Outperform” on Monday, February 27. Deutsche Bank initiated Invitation Homes Inc. (NYSE:INVH) rating on Monday, February 27. Deutsche Bank has “Buy” rating and $25.0 target. Evercore initiated the shares of INVH in report on Monday, June 5 with “Outperform” rating. The company was initiated on Monday, February 27 by Goldman Sachs. The firm earned “Buy” rating on Friday, December 8 by Citigroup.

Invitation Homes Inc. engages on owning, renovating, leasing, and operating single-family residential properties in the United States. The company has market cap of $11.47 billion. It has approximately 50,000 homes for lease in 13 markets. It currently has negative earnings.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:

Recent Market News